Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The A2B adenosine receptor protects against inflammation and excessive vascular adhesion
Dan Yang, … , Denisa D. Wagner, Katya Ravid
Dan Yang, … , Denisa D. Wagner, Katya Ravid
Published July 3, 2006
Citation Information: J Clin Invest. 2006;116(7):1913-1923. https://doi.org/10.1172/JCI27933.
View: Text | PDF
Research Article Cardiology

The A2B adenosine receptor protects against inflammation and excessive vascular adhesion

  • Text
  • PDF
Abstract

Adenosine has been described as playing a role in the control of inflammation, but it has not been certain which of its receptors mediate this effect. Here, we generated an A2B adenosine receptor–knockout/reporter gene–knock-in (A2BAR-knockout/reporter gene–knock-in) mouse model and showed receptor gene expression in the vasculature and macrophages, the ablation of which causes low-grade inflammation compared with age-, sex-, and strain-matched control mice. Augmentation of proinflammatory cytokines, such as TNF-α, and a consequent downregulation of IκB-α are the underlying mechanisms for an observed upregulation of adhesion molecules in the vasculature of these A2BAR-null mice. Intriguingly, leukocyte adhesion to the vasculature is significantly increased in the A2BAR-knockout mice. Exposure to an endotoxin results in augmented proinflammatory cytokine levels in A2BAR-null mice compared with control mice. Bone marrow transplantations indicated that bone marrow (and to a lesser extent vascular) A2BARs regulate these processes. Hence, we identify the A2BAR as a new critical regulator of inflammation and vascular adhesion primarily via signals from hematopoietic cells to the vasculature, focusing attention on the receptor as a therapeutic target.

Authors

Dan Yang, Ying Zhang, Hao G. Nguyen, Milka Koupenova, Anil K. Chauhan, Maria Makitalo, Matthew R. Jones, Cynthia St. Hilaire, David C. Seldin, Paul Toselli, Edward Lamperti, Barbara M. Schreiber, Haralambos Gavras, Denisa D. Wagner, Katya Ravid

×

Figure 4

E-selectin, P-selectin, and ICAM-1 levels are augmented and IκB-α levels are reduced in the A2B AR-KO mice.

Options: View larger image (or click on image) Download as PowerPoint

                  E-selectin, P-selectin, and ICAM-1 levels are augment...
(A) Western blot analysis of protein extracts isolated from mesenteric arteries derived from WT and KO mice. Despite attempts to dissect an endothelial layer from a mouse artery, the preparation was accompanied with VSMCs. vWF is only expressed in endothelial cells and, hence, serves as an appropriate marker for this cell type. Samples were subjected to Western blotting with the indicated antibodies. (B) Quantification of the Western blot analyses of WT and A2BAR-KO samples shown in A. Probing with anti-actin was used to generally reflect protein loading. Protein levels on the Western blots were assessed and normalized to the level of vWF, which represents the fraction of endothelial cells within the loaded protein. Quantification was performed using NIH ImageJ software (version 1.62; http://rsb.info.nih.gov/ij/). The data shown represents the average ± SD of 3 experiments.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts